F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma.

TB, Bartel; J, Haessler; TL, Brown; JD Jr, Shaughnessy; Rhee F, van; E, Anaissie; T, Alpe; E, Angtuaco; R, Walker; J, Epstein; J, Crowley; B, Barlogie

doi:10.1182/blood-2009-03-213280

Public

F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma.

Shared by NobleBlocks on May 14, 2009 • 12:00 AM UTC

Authors:

Bartel TB

Haessler J

Brown TL

Abstract

F18-fluorodeoxyglucose positron emission tomography (FDG-PET) is a powerful tool to investigate the role of tumor metabolic activity and its suppression by therapy for cancer survival. As part of Total Therapy 3 for newly diagnosed multiple myeloma, metastatic bone survey, magnetic resonance imaging...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!